Obesity
I'm on a weight-loss injection and I need an operation. Do I have to stop the drug first?
Korean anaesthetists say no, for most patients. The recommendation is a day of clear fluids and an ultrasound of the stomach if emptying is in doubt — not stopping the injection.
Answer
Most patients should not stop: consensus recommendations from the Clinical Practice Guideline Committee of the Korean Society of Anesthesiologists advise continuing GLP-1 receptor agonist therapy in most patients with individualised risk assessment, considering a 24-hour clear liquid diet before anaesthesia, and using preanaesthetic gastric ultrasound when delayed gastric emptying is suspected — while stating explicitly that current evidence is insufficient to support formally evidence-graded guidelines, so these are expert consensus rather than graded recommendations.
Key takeaways
- The recommendations come from the Clinical Practice Guideline Committee of the Korean Society of Anesthesiologists.
- GLP-1 receptor agonist therapy should be continued in most patients, with risk assessed individually rather than stopped routinely.
- A 24-hour clear liquid diet before anaesthesia is put forward for consideration.
- Preanaesthetic gastric ultrasound is recommended when delayed gastric emptying is suspected.
- The committee states that current evidence is insufficient to support formally evidence-graded clinical practice guidelines.
- Pulmonary aspiration is uncommon but carries substantial morbidity and mortality.
- Standard fasting intervals do not guarantee an empty stomach, which was true before these drugs existed.
The worry is legitimate and mechanical. These drugs work partly by slowing how fast the stomach empties, and under general anaesthesia the reflexes that keep stomach contents out of the lungs are lost. So the question of whether to pause the injection before surgery follows directly.
The recommendation is to continue
The Korean position is that these medications should be continued in most patients, with risk assessed case by case. That is worth stating plainly, because the intuitive answer — stop it to be safe — carries costs of its own: interrupted glycaemic control, weight regain, and patients who never restart.
Why fasting rules were never enough
The document's starting point is broader than one drug class. Sticking to a fasting interval does not guarantee an empty stomach and never did — diabetes, obesity, pain, opioids, pregnancy and anxiety all slow emptying. These injections have exposed an existing weakness in the standard approach rather than creating a new problem.
What kind of guidance this is
The committee is unusually direct about its own standing: the evidence base is insufficient to formally support evidence-graded guidelines, and these recommendations were developed through expert discussion where robust evidence is lacking. No trial has measured aspiration rates with and without these precautions. That is a reason to read the recommendation as sensible practice rather than as settled fact.
The short version for a patient: tell the anaesthetist you are on the drug, well before the day. Expect to be asked to take clear fluids only for about a day rather than to stop the injection. And if an ultrasound of your stomach is done before you go under, that is a precaution being taken, not a sign something has gone wrong.
Sources
- 1
Bang YJ, Choi JH, Min JJ, Park SY, Choi WK, Hwang JY, Koo BN
Korean consensus-based recommendations for preanesthetic gastric ultrasound and anesthetic considerations for GLP-1 receptor agonist-based therapy: a consensus statement from Clinical Practice Guideline Committee of the Korean Society of AnesthesiologistsKorean Journal of Anesthesiology 2026
doi:10.4097/kja.26655 · PMID:42529794
https://doi.org/10.4097/kja.26655
Related
FAQ · Obesity
Can the weight-loss injection cause depression or anxiety?
Korean records from 13 hospitals found a psychiatric signal for both semaglutide and liraglutide. Whether the drug causes it, or the people who seek it were already more distressed, the data cannot say.
Chloe Moon5 min read
News · Obesity
After weight-loss surgery Koreans were 1.8 times as likely to stop their long-term gout drug. The attack medication did not follow
3,804 operated patients against 15,240 matched controls. Urate-lowering therapy fell to control levels by month 13; acute medication use fell too, and stayed above controls throughout.
Chloe Moon6 min read
News · Obesity
116 Korean patients followed for two years after weight-loss surgery: the weight came back a little, the quality of life did not
Total weight loss peaked at 27.5 percent at eighteen months and settled at 24.7 percent at two years. Diabetes remission went the other way, rising from 80.7 to 85.7 percent.
David Seo6 min read